Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Peter Grützmacher"'
Autor:
Volker J J, Schettler, Christian, Peter, Thomas, Zimmermann, Ulrich, Julius, Eberhard, Roeseler, Georg, Schlieper, Franz, Heigl, Peter, Grützmacher, Iris, Löhlein, Reinhard, Klingel, Bernd, Hohenstein, Wolfgang, Ramlow, Anja, Vogt
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyREFERENCES. 26
During 2012-2020, 89 German apheresis centers collected retrospective and prospective observational data of 2028 patients undergoing regular lipoprotein apheresis (LA) for the German Lipoprotein Apheresis Registry (GLAR). More than 47 500 LA sessions
Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
Publikováno v:
Clinical Research in Cardiology Supplements
General lipoprotein (Lp) (a) screening can help to identify patients at high risk for cardiovascular disease. Non-invasive methods allow early detection of clinically asymptomatic incipient atherosclerotic disease. Medical treatment options are still
Publikováno v:
CardioVasc. 17:40-42
Publikováno v:
CardioVasc. 16:38-40
Autor:
Stefan Krzossok, Peter Grützmacher
Publikováno v:
Dialyse aktuell. 11:26-41
Die renale Anamie ist eine Komplikation bei chronischer Niereninsuffizienz, die mit einer erhohten Morbiditat und Mortalitat assoziiert ist. Die Therapie mit rekombinantem Erythropoetin verbessert die Lebensqualitat und verringert die Hospitalisierun
Publikováno v:
CardioVasc. 15:34-35
Autor:
Peter Grützmacher, Claudius Kleinert
Publikováno v:
Clinical Research in Cardiology Supplements
For long-term lipid apheresis therapy, several different technical systems have been developed which enable effective reduction of LDL cholesterol and other atherogenic lipoproteins, such as Lp(a), with sufficient selectivity and good clinical tolera
Publikováno v:
American Journal of Nephrology. 11:54-60
The substitution of recombinant human erythropoietin (rhEPO) in chronic hemodialysis patients is often associated with the development of severe hypertension. In the present study, a systematical echocardiographic analysis was performed in 25 patient
Publikováno v:
Blood Purification. 8:272-278
Cardiomegaly and impaired cardiac function induced by renal anemia are frequent findings in patients with chronic renal failure. The present investigation was performed to study the cardiac effects of a therapy with recombinant human erythropoietin i
Autor:
Frank Thévenod, Radtke Hw, Heinz W. Radtke, Elisabeth Vincent, Koch Km, Peter Grützmacher, Wilhelm Schoeppe, Winfried Fassbinder
Publikováno v:
Kidney International. (2):227-232
Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia. Anemia of endstage renal failure improves shortly after kidney transplantation. However, in about 10% of transplanted patients polycythemia occurs. By us